VAERS Datenanalyse und Statistik
VAERS DatenanalyseSuche nach Chargen, Symptomen, Reports und Statistiken
Zurueck zur Suche

Reporte zur Charge U7596AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 2 MI 2 IL 1 RI 1 CT 1 IN 1 NJ 1 PA 1

VAERS 2595096

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge u7596ab

moderat
Staat
MI
Alter
17,0
Geschlecht
F
Eingang
16.03.2023
Impfdatum
09.03.2023
Beginn
10.03.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Arthralgia Blood test C-reactive protein increased Chest discomfort Chills Computerised tomogram thorax normal Dyspnoea Echocardiogram Computerised tomogram normal Drug screen negative Dyspnoea at rest Dysstasia Electrocardiogram normal Erythema Fibrin D dimer Full blood count normal Electrocardiogram Fatigue

Symptomtext

On 3/10 began having soreness on Right Arm. Noted to have a clementine sized area of erythema and swelling with shortness of breath rest. Heart Rate was 124 at that time. Also experienced chills with no fever. PCP was contacted and was told to monitor overnight. On 3/11 in the morning was having trouble standing up and experiencing shortness of breath and nausea. Chest felt uncomfortable. Her right shoulder was hurting. At this time, PCP was contacted again and was instructed to go to the ER. ER did ekg, CT, echocardiogram and bloodwork. Toponin level was elevated - 0.11, 0.14, and 0.08. CRP was elelvated at 84, ESR elevated at 31, and D-dimer elevated at 832. CBC, CMP, urine drug screen, CT, and EKG all normal .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
3/11 Troponin levels o 0.11, 0.14, and 0.08. CRP 84, ESR 31, D Dimer 832
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2537915

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7596AB

moderat
Staat
-
Alter
16,0
Geschlecht
F
Eingang
20.12.2022
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Fall Feeling abnormal Hypertension Tremor

Symptomtext

after receiving Menatra and Trumemba pt was sitting in room with mom and stated she didn't feel right, then eyes closed and fell to side onto medical table pt was sitting on, mom reports upper and lower b/l shaking of extremities, all lasting < 20-30seconds. no color change. pt came too before I entered the room and cool compress applied, and advised to drink water. HR and BP rechecked, BP slight high, rechecked again in 5mins and nl for pt. nl heart physical exam. pt reports feeling completely normal prior to leaving office and spent another 15mins in office to evaluate finger that she also wanted PE clearance for at time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypertension
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670909

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7596AB

mild
Staat
IL
Alter
11,0
Geschlecht
F
Eingang
14.08.2023
Impfdatum
14.08.2023
Beginn
14.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blindness Dizziness Skin warm

Symptomtext

5 MINUTES AFTER VACCINE WAS ADMINISTRED, PATINET STARTED COMPLAINING OF FEELING LITTLE DIZZY AND NOT ABLE TO SEE AT ALL FOR 10 MINUTES.PT WAS HOT TO TOUCH.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
NO TEST WERE DONE. PT WAS GIVEN ICE PACKS TO HOLD AND COLD WATER. PT WAS ADVISED TO CLOSE EYES FOR FEW MINUTES AND PT STARTED FEELING BETTER. CALLED PATINET AFTER 1 HRS TO CHECK ON HER, SHE IS FEELING NORMAL AND NO SYMPTOMS ANYMORE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2655879

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge u7596ab

mild
Staat
RI
Alter
11,0
Geschlecht
F
Eingang
13.07.2023
Impfdatum
11.07.2023
Beginn
12.07.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Discomfort Injection site swelling Pruritus

Symptomtext

There's little swelling around site on one arm. But, she suddenly became itchy, uncomfortable all over with no visible skin rash

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Triamcinolone
Allergien
N/A
Vorherige Impfungen
-

VAERS 2711220

UNKNOWN MANUFACTURER · MENINGOCOCCAL (NO BRAND NAME) · Charge U7596AB

gering
Staat
CT
Alter
-
Geschlecht
U
Eingang
07.11.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered Product storage error

Symptomtext

MENQUADFI reached 1C and was then administered with no reported adverse event; Initial information was received on 24-Oct-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age and unknown gender patient who reported that meningococcal a-c-y-w135 (t conj) vaccine [Menquadfi] reached 1c and was then administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a unknown dose of suspect meningococcal a-c-y-w135 (t conj) vaccine (Solution for injection) (strength not reported, lot U7596AB, Expiry date : 14-Mar-2025) via unknown route in unknown administration site for Prophylactic vaccination (Immunization) and menquadfi reached 1c and was then administered with no reported adverse event (poor quality product administered) (latency: same day) following the administration of meningococcal a-c-y-w135 (t conj) vaccine. Reportedly "Inquiry placed in proxy for final handling. Medical assistant requesting stability information regarding temperature excursion. Products: ACTHIB, PENTACEL, MENQUADFI and IPOL (all unopened). Reason: Occurred during recalibration of new thermometer. Max/low temperature reached: 33.8F minimum and 43.7F maximum. Duration out of labelled range: 47 minutes Human error? NO Does extended stability data cover the excursion? NO If negative advice, was the product administered to a patient? YES verified email address with caller. See associated case 01817531. Attempted to warm transfer caller, but none were available. Caller did not have patient information available at time of call. " Action taken with meningococcal vaccine (Menquadfi) was not applicable. At time of reporting, the outcome was Unknown for the event menquadfi reached 1c and was then administered with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670087

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7596AB

gering
Staat
IN
Alter
11,0
Geschlecht
F
Eingang
11.08.2023
Impfdatum
10.08.2023
Beginn
10.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

Patient received 4 vaccines during appointment. Patient's guardian, authorized 2 of the 4 vaccinations (Tdap and Meningococcal). Patient's guardian was present during administration of the vaccines. After the patient and her guardian left the office, it was found that the guardian only authorized the 2 vaccines. Health Department left voicemail on guardian's cell at 4:31 PM. Health Department spoke to guardian on Friday, August 11 at 8:25 AM. Guardian stated outrage regarding the administering of the 2 other vaccinations and requested documentation regarding her consent. Side effects and vaccine appropriateness explained. Requested documentation and educational materials were placed in the mail today at 9:05 AM.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2665068

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7596AB

gering
Staat
NJ
Alter
16,0
Geschlecht
M
Eingang
02.08.2023
Impfdatum
24.07.2023
Beginn
24.07.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event Wrong product administered

Symptomtext

Patient was given an extra dose of Menquadfi. Pt was originally scheduled to receive Bexsero second dose. Pt completed their series with Menquadfi. No reaction after vaccination and followed up with pt's parent and states that they are good. Spoke with vaccine manufacturer and states that there is no harm to patient in receiving an extra dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
none
Andere Medikamente
none
Allergien
N.K.D.A.
Vorherige Impfungen
-

VAERS 2621156

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U7596AB

gering
Staat
NY
Alter
0,3
Geschlecht
M
Eingang
25.04.2023
Impfdatum
19.04.2023
Beginn
19.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

menactra was administered to a patient of age 4 month with no adverse event; Initial information was received on 20-Apr-2023 regarding an unsolicited valid non-serious case from a physician. This case involves a meningococcal a-c-y-w135 (d conj) vaccine [Menactra] was administered to 4 months old male patient with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, hib vaccine conj (tet tox), pertussis vaccine acellular 5-component, polio vaccine inact 3v (mrc 5), tetanus vaccine toxoid (Pentacel) for Prophylactic vaccination (Immunisation) and Rotovax. On 19-Apr-2023, the patient of age 4 months received a dose of 0.5 ml total suspect of meningococcal A-C-Y-W135 (D CONJ) vaccine Solution for injection (lot number: U7596AB, expiration date: 14-Mar-2025) via intramuscular route in the thigh nos for immunizations (immunisation) with no adverse event (product administered to patient of inappropriate age) (latency: same day). No lab data reported. Action taken: not applicable. Outcome was Unknown for the event menactra was administered to a patient of age 4 month with no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PENTACEL
Allergien
-
Vorherige Impfungen
-

VAERS 2618473

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7596AB

gering
Staat
NY
Alter
0,3
Geschlecht
M
Eingang
20.04.2023
Impfdatum
19.04.2023
Beginn
20.04.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Patient reviewed Menquadfi in error instead of Prevnar. When I called parents upon realization of error made, parents report patient has no reactions at time of call/this reporting. Advised to call for any concerns or side effects right away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
No meds
Allergien
No allergies
Vorherige Impfungen
-

VAERS 2615414

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7596AB

gering
Staat
PA
Alter
19,0
Geschlecht
F
Eingang
14.04.2023
Impfdatum
14.04.2023
Beginn
14.04.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Hepatitis B antibody negative Wrong product administered

Symptomtext

PATIENT CAME FOR HEP B SERIES , AND RCEIVED MENQUADFI

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
UNKNOWN
Allergien
NONE
Vorherige Impfungen
MENNIGICOCCAL B ADVERSE REACTION BELLS PALSY

VAERS 2583327

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENQUADFI) · Charge U7596AB

gering
Staat
MI
Alter
18,0
Geschlecht
F
Eingang
17.02.2023
Impfdatum
13.02.2023
Beginn
13.02.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Wrong product administered

Symptomtext

accidentally injected with MENQUADFI instead of a Meningococcal B vaccine, with no reported adverse event; Initial information received on 14-Feb-2023 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves an 18-year-old female patient to whom accidentally injected with MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] instead of a meningococcal b vaccine, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Feb-2023, the patient received dose 3 at 0.5ml (frequency: once) of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (formulation: unknown) (strength: standard, 0.5ml) (lot number: U7596AB and expiry date: 14-Mar-2025) via intramuscular route in the left deltoid for Immunization and on the same day patient was accidentally injected with menquadfi instead of a meningococcal b vaccine, with no reported adverse event (wrong product administered). It was reported, the medical assistant (MA) asks if there is an issue with taking MENQUADFI so close together, what to expect, and how long they should wait until they give the Meningococcal B vaccine. Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-